ALS Variants of Annexin A11's Proline-Rich Domain Impair Its S100A6-Mediated Fibril Dissolution

ACS Chem Neurosci. 2023 Aug 2;14(15):2583-2589. doi: 10.1021/acschemneuro.3c00169. Epub 2023 Jul 11.

Abstract

Mutations in the proline-rich domain (PRD) of annexin A11 are linked to amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, and generate abundant neuronal A11 inclusions by an unknown mechanism. Here, we demonstrate that recombinant A11-PRD and its ALS-associated variants form liquidlike condensates that transform into β-sheet-rich amyloid fibrils. Surprisingly, these fibrils dissolved in the presence of S100A6, an A11 binding partner overexpressed in ALS. The ALS variants of A11-PRD showed longer fibrillization half-times and slower dissolution, even though their binding affinities for S100A6 were not significantly affected. These findings indicate a slower fibril-to-monomer exchange for these ALS variants, resulting in a decreased level of S100A6-mediated fibril dissolution. These ALS-A11 variants are thus more likely to remain aggregated despite their slower fibrillization.

Keywords: Intrinsically disordered regions; NMR; SPR; amyloids; neurodegenerative diseases; phase separation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amyloid / metabolism
  • Amyotrophic Lateral Sclerosis* / genetics
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Annexins / genetics
  • Cell Cycle Proteins / chemistry
  • Cell Cycle Proteins / metabolism
  • Humans
  • Neurodegenerative Diseases*
  • Proline / genetics
  • S100 Calcium Binding Protein A6
  • Solubility

Substances

  • Annexins
  • Amyloid
  • Proline
  • S100A6 protein, human
  • S100 Calcium Binding Protein A6
  • Cell Cycle Proteins